ALNY

#365
Alnylam Pharmaceuticals, Inc. - Common Stock
302.3 1 USD
-0.62%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
300.80
305.68
Faixa anual
284.28
495.55
Mudança diária
-0.62%
Mudança mensal
-1.68%
Mudança em 6 meses
-32.81%
Mudança anual
+5.26%
Fechamento anterior
304.2 0
Open
302.4 3
Mínimo
300.8 0
High
305.6 8
Volume
460
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 40.36 B
  • Employee 2 500
  • Founded 2002
  • CEO Yvonne Greenstreet
  • Website www.alnylam.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BFGNJ5
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
170.67
Índice preço/fluxo de caixa
14.42

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Notícias